Ask AI
ProCE Banner Series

Advancing T-Cell Lymphoma Care Through Novel Personalized Treatment Approaches

Register for this webinar to learn from experts about the latest clinical trial data on planning individualized treatments in the care of patients with T-cell lymphomas.

To Register: Please click the green “Learn More” button below. On the next page, select Register for “Virtual Event.” Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  AMA
Who Should Attend

This educational program is intended for hematologists, oncologists, hematologist-oncologists, and other healthcare professionals caring for patients with T-cell lymphomas.

All Events

Advancing T-Cell Lymphoma Care Through Novel Personalized Treatment Approaches

Past Events

January

05

2024

1:00 PM - 2:30 PM Eastern Time (ET)

Virtual

Topics

  • Modern Molecular and Phenotypic Workup for T-Cell Lymphomas
  • New Treatment Paradigms in Frontline Treatment for Nodal Subtypes and Improving Outcomes for Relapsed/Refractory Peripheral T-Cell Lymphoma
  • Planning Treatment for Frontline and Relapsed/Refractory Cutaneous T-Cell Lymphoma Subtypes
  • Novel Agents for Mycosis Fungoides and Sézary Syndrome

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This program aims to improve learners’ knowledge, confidence, and competence in integrating recent approvals, emerging clinical data, and adverse event management into clinical practice for the treatment of T-cell lymphomas. 

Target Audience
This educational program is intended for hematologists, oncologists, hematologist-oncologists, and other healthcare professionals caring for patients with T-cell lymphomas. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Plan individualized treatment decisions in patients with T-cell lymphomas leveraging guideline recommendations based on an assessment of molecular/phenotypic biomarkers and accurate lymphoma subclassification
  • Evaluate the latest clinical trial data for novel agents and emerging therapeutic strategies for newly diagnosed and relapsed/refractory T-cell lymphomas
  • Manage treatment-related adverse events through agent familiarity and robust monitoring efforts
  • Identify all patients, regardless of race, age, or gender, with T-cell lymphomas who would likely benefit from enrollment in a clinical trial

Accreditation

Joint Accreditation Statement

A logo with a triangle in a circleDescription automatically generated

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Kyowa Kirin, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191